Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AVANOS MEDICAL, INC. Director's Dealing 2021

Mar 19, 2021

32765_dirs_2021-03-19_d74d1766-17dd-46d7-8a72-71dde3c918cd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Avanos Medical, Inc. (AVNS)
CIK: 0001606498
Period of Report: 2021-03-17

Reporting Person: Negro Renato (Vice President - Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-17 Common Stock A 2379 $47.29 Acquired 25874 Direct

Footnotes

F1: Represents annual grant of time-vested restricted stock units awarded to Reporting Person on 3/17/2021, with a 3 year cliff vesting period.